Brian Joseph Cahill
CIK 1831591 · CHIEF FINANCIAL OFFICER · last filed 2024-02-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
20
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | CHIEF FINANCIAL OFFICER | 47,958 | $2.14 | $102.6K | $0 | 20 | 2024-02-29 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-04 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −805 | -$36.2K | EDGAR |
| 2022-02-01 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −626 | -$28.8K | EDGAR |
| 2022-01-11 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −263 | -$13.3K | EDGAR |
| 2022-01-07 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −738 | -$37.4K | EDGAR |
| 2021-12-21 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −467 | -$25.9K | EDGAR |
| 2021-02-04 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | +8,900 | $0 | EDGAR |
| 2021-02-02 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −637 | -$29.7K | EDGAR |
| 2021-01-22 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2021-01-11 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −237 | -$12.1K | EDGAR |
| 2021-01-07 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −746 | -$37.3K | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.